Meningococcal Vaccines Market Overview, Trends, Opportunities, Growth and Forecast to 2024-2032

 The latest report by IMARC Group, titled “Meningococcal Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global meningococcal vaccines market size reached US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 7.7% during 2024-2032.

Meningococcal vaccines are essential immunizations designed to protect individuals from bacterial infections caused by Neisseria meningitidis, commonly known as meningococcal bacteria. These vaccines safeguard public health by preventing life-threatening illnesses such as meningitis and septicemia. There are several types of meningococcal vaccines available, with the most common being the conjugate vaccines and the serogroup B vaccines. Additionally, conjugate vaccines are highly effective and target specific strains of meningococcal bacteria, including A, C, W, and Y, which are typically administered to adolescents and young adults. Serogroup B vaccines are developed to combat meningococcal serogroup B infections, responsible for outbreaks in various regions, and offer protection to individuals at higher risk. Nowadays, meningococcal vaccines work by stimulating the immune system to generate antibodies against the bacteria, thereby preventing infection.  

Meningococcal Vaccines Market Trends and Drivers:

The market for meningococcal vaccines is primarily driven by the growing awareness of meningococcal diseases among the general population and healthcare professionals. In addition, meningococcal diseases caused by the Neisseria meningitidis bacteria can lead to severe health complications, including meningitis and septicemia, thus influencing market growth. Moreover, the pharmaceutical industry has made substantial progress in developing more effective and safer meningococcal vaccines, including the development of conjugate vaccines that provide longer-lasting immunity and broader protection against multiple strains of the bacteria, representing another major growth-inducing factor. Along with this, companies are investing in research and development (R&D) efforts, leading to the introduction of new vaccines and increased competition, thus propelling market growth. Besides this, the increasing improvements in healthcare infrastructure and easy access to medical services in developing countries led to the growth of the meningococcal vaccine market, thus accelerating the market growth. 

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/meningococcal-vaccines-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Vaccine Type:

  • Conjugate
  • Polysaccharide
  • Subcapsular

Breakup by Composition:

  • Mono Vaccines
  • Combination Vaccines

Breakup by Vaccine Serotype:

  • MenACWY
  • MenB & Manic
  • MenC
  • MenA
  • MenAC
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others

Breakup by End User:

  • Pediatric
  • Adult

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • GlaxoSmithKline Plc
  • Hualan Biological Engineering Inc.
  • Incepta Pharmaceuticals Limited
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Ltd. 
  • Walvax Biotechnology Co. Ltd.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163

 

Comments

Post a Comment

Popular posts from this blog

Retail Market 2024-2032: Industry Growth, Share, Trends, Analysis and Research Report

Image
The latest report by IMARC Group, titled “ Retail Market Report by Product (Food and Beverages, Personal and Household Care, Apparel, Footwear and Accessories, Furniture, Toys and Hobby, Electronic and Household Appliances, and Others), Distribution Channel (Supermarkets and Hypermarkets, Convenience Stores, Specialty Stores, Online Stores, and Others), and Region 2024-2032 “, The global retail market size  reached US$ 28,514.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 46,304.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.54% during 2024-2032.  The retail sector consists of a diverse array of businesses that directly sell goods and services to consumers. This industry includes various types of establishments, such as physical stores, online platforms, and vending machines. Retailers play a vital role in connecting producers with consumers, acting as the final link in the distribution chain. Ranging from large supermarket chains to s...
Read more

Payment Gateways Market 2024-2032: Global Size, Share, Growth, Trends and Forecast

Image
IMARC Group's report titled " Payment Gateways Market Report by Application (Large Enterprises, Micro and Small Enterprises, Mid-Size Enterprises), Mode of Interaction (Hosted Payment Gateways, Pro/Self-Hosted Payment Gateways, API/Non-Hosted Payment Gateways, Local Bank Integrates, Direct Payment Gateways, Platform-Based Payment Gateways), and Region 2024-2032 ". The global payment gateways market size reached US$ 24.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 42.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032. Factors Affecting the Growth of the Payment Gateways Industry: E-commerce Growth: The payment gateways market is greatly influenced by the rapid expansion of e-commerce on a global scale. With more businesses adopting online sales platforms and consumers favoring digital shopping experiences, the need for secure and efficient payment processing solutions is on the rise. Payment gateways play a crucial ...
Read more

Remote Patient Monitoring Market Trends 2023 Industry Demand, Revenue Growth and Competitive Analysis Forecast to 2028

Image
The latest report by IMARC Group, titled “ Remote Patient Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 “, The global remote patient monitoring market size reached US$ 1.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.96 Billion by 2028, exhibiting a growth rate (CAGR) of 15.4% during 2023-2028.  Remote Patient Monitoring (RPM) is a healthcare practice that utilizes advanced technology to monitor the health of a patient remotely. It involves the collection, analysis, and transmission of patient data to healthcare providers, allowing for continuous monitoring of vital signs, symptoms, and other health-related metrics. This innovative approach has gained significant importance, especially in the context of modern healthcare, where the need for personalized, real-time care has grown substantially. RPM typically involves the use of various devices and sensors that patients can use in ...
Read more